Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Benign Prostatic Hyperplasia Treatment Market Through 2034?
Over the past few years, there has been a significant expansion in the market size for benign prostatic hyperplasia treatment. It is projected to increase from $8.23 billion in 2024 to $8.69 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.5%. Factors such as enhanced awareness and targeted screening initiatives, a higher incidence rate of BPH, an increased understanding of healthcare, improved healthcare facilities, and an aging population, have contributed to the growth observed during the historic period.
The market size for benign prostatic hyperplasia treatment is projected to experience substantial growth in the near future. It is anticipated to increase to$10.74 billion in 2029 with a compound annual growth rate (CAGR) of 5.5%. This advancement during the forecasting period may be due to the growing use of minimally invasive practices, an increasing count of elderly patients, improved availability of cutting-edge treatment choices, an intensified focus on patient-oriented care, and a surge in the number of related health complications. Future trends within the forecasted timeframe encompass the development of tailored therapies, incorporation of online health solutions, advancements in surgical alternatives, assimilation of 3D imaging for diagnostic purposes, and innovation in patient-centric care frameworks.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21112&type=smp
What External and Internal Drivers Are Contributing to the Growth of theBenign Prostatic Hyperplasia Treatment Market?
The growth of the benign prostatic hyperplasia treatment market is expected to be bolstered by the increasing use of minimally invasive surgeries. These are surgical procedures that involve small or no incisions made using specialized instruments, with the added advantages of quicker recovery time, less pain and a lesser likelihood of complications. Shifting preferences toward minimally invasive surgeries have been attributed to benefits like faster recovery, alleviated pain, minimization of complication risks, and enhanced aesthetic results. Implementing minimally invasive surgeries for treating benign prostatic hyperplasia results in lesser recovery time, reduced likelihood of complications, and practical symptom relief, thereby improving overall surgical results. For instance, the American Society of Plastic Surgeons (ASPS), a professional association located in the US, stated in September 2023 that in 2022, globally, there were 23,672,269 cosmetic minimally invasive procedures undertaken, which included treatments like neuromodulator injections, lip augmentation, and non-invasive skin tightening. Therefore, the increasing acceptance of minimally invasive surgeries is fueling the expansion of the benign prostatic hyperplasia treatment market.
What Segment Types Define the Benign Prostatic Hyperplasia Treatment Market Structure?
The benign prostatic hyperplasia treatmentmarket covered in this report is segmented –
1) By Treatment: Minimal Invasive Surgery; Invasive Surgery
2) By Therapeutic Class: Alpha Blockers; 5-Alpha Reductase Inhibitors; Phosphodiesterase-5 Inhibitors; Other Therapeutic classes
3) By End User: Home Healthcare; Hospitals And Clinics; Research And Manufacturing
Subsegments:
1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP); Laser Surgery; Prostatic Urethral Lift; Transurethral Incision of the Prostate (TUIP); Microwave Therapy
2) By Invasive Surgery: Open Prostatectomy; Robotic Prostatectomy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21112&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Benign Prostatic Hyperplasia Treatment Market?
North America was the largest region in the benign prostatic hyperplasia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benign prostatic hyperplasia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Long-Term Trends Are Transforming the Competitive Landscape of the Benign Prostatic Hyperplasia Treatment Market?
Key players in the benign prostatic hyperplasia treatment industry are striving to create innovative solutions, such as minimally invasive procedures, to improve patient outcomes and reduce recovery durations. These types of procedures use small or no incisions, resulting in less trauma, pain, and potential complications, while also promoting a quicker recovery than conventional surgical methods. For instance, in December 2022, Teleflex Incorporated, a medical device firm based in the US, introduced the UroLift System designed for treating benign prostatic hyperplasia. This system employs tiny, permanent implants to adjust the position of enlarged prostate tissue, providing substantial relief from symptoms without the need for tissue removal, cutting, or heating. This outpatient procedure allows for a swift recovery, maintains sexual function, and results in superior relief from symptoms compared to usual BPH medicines. Known side effects usually clear up within two to four weeks.
View the full report here:
What Is the Definition of the Benign Prostatic Hyperplasia Treatment Market?
Benign prostatic hyperplasia (BPH) treatment refers to medical, minimally invasive, and surgical approaches used to manage the symptoms of an enlarged prostate. BPH is a common condition in aging men, leading to urinary issues such as frequent urination, weak stream, and incomplete bladder emptying.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21112
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model